Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentgerm cell nucleus

TAF3 TAF7 TOP1 TOP2A MARCKS

1.97e-05113615GO:0043073
GeneOntologyCellularComponentmale germ cell nucleus

TAF3 TAF7 TOP1 TOP2A

1.17e-0486614GO:0001673
GeneOntologyCellularComponentdendritic branch

AKAP9 MARCKS

1.74e-047612GO:0044307
GeneOntologyCellularComponentrod photoreceptor outer segment

TMEM237 CNGA1

2.98e-049612GO:0120200
GeneOntologyCellularComponentactin filament bundle

TPM4 DST DIAPH3 MARCKS

3.93e-04118614GO:0032432
Domain-

RASA4 RASA4B

3.04e-0536024.10.1130.10
DomainBTK

RASA4 RASA4B

3.60e-049602SM00107
DomainZnf_Btk_motif

RASA4 RASA4B

3.60e-049602IPR001562
DomainBTK

RASA4 RASA4B

3.60e-049602PF00779
DomainZF_BTK

RASA4 RASA4B

3.60e-049602PS51113
DomainRasGAP

RASA4 RASA4B

9.01e-0414602SM00323
DomainRasGAP_CS

RASA4 RASA4B

9.01e-0414602IPR023152
DomainRasGAP

RASA4 RASA4B

1.04e-0315602PF00616
DomainRAS_GTPASE_ACTIV_1

RASA4 RASA4B

1.04e-0315602PS00509
DomainRAS_GTPASE_ACTIV_2

RASA4 RASA4B

1.04e-0315602PS50018
Domain-

RASA4 RASA4B

1.18e-03166021.10.506.10
DomainRasGAP_dom

RASA4 RASA4B

1.50e-0318602IPR001936
Domain-

RASA4 DAB2 DNM3 RASA4B PLCB4 FERMT3

1.56e-033916062.30.29.30
DomainPH_dom-like

RASA4 DAB2 DNM3 RASA4B PLCB4 FERMT3

2.41e-03426606IPR011993
DomainActinin_actin-bd_CS

DST UTRN

2.46e-0323602IPR001589
DomainSpectrin

DST UTRN

2.46e-0323602PF00435
DomainACTININ_2

DST UTRN

2.46e-0323602PS00020
DomainACTININ_1

DST UTRN

2.46e-0323602PS00019
DomainSpectrin_repeat

DST UTRN

3.90e-0329602IPR002017
DomainSpectrin/alpha-actinin

DST UTRN

4.73e-0332602IPR018159
DomainSPEC

DST UTRN

4.73e-0332602SM00150
DomainPH

RASA4 DNM3 RASA4B FERMT3

6.28e-03229604PF00169
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

ORC2 ILF2 DST RPLP1 ZSCAN21 TMEM237 RBBP6 PHF3 ANKRD11 SRSF11 CHD1L KAT2A CPSF2 IK TAF7 SRRM2 TOP1 TOP2A ATP5F1C

4.10e-131294611930804502
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

ORC2 TAF3 SERBP1 ILF2 ZSCAN21 ACAT1 RBBP6 PHF3 ANKRD11 SRSF11 IK SRRM2 TOP1 MRPL1 TOP2A SDHB ATP5F1C

4.24e-13954611736373674
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

ORC2 TAF3 ILF2 LMAN1 RPLP1 ACAT1 RBBP6 IARS1 SRSF11 CHD1L CPSF2 DCK SRRM2 PSMA8 TOP1 MRPL1 TOP2A FERMT3 ATP5F1C

5.67e-131318611930463901
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

CYLC1 TPM4 SPAG1 DST RARG RPLP1 FAM186A SEC62 SRSF11 KAT2A DIAPH3 SPAG17 RNF17 PSMA8 TOP1 TOP2A ATP5F1C

2.74e-101442611735575683
Pubmed

ATG5 is required for B cell polarization and presentation of particulate antigens.

TPM4 SERBP1 ILF2 RPLP1 ACAT1 RBBP6 CPSF2 IK TOP1 TOP2A FERMT3 ATP5F1C

2.89e-09701611230196744
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

SERBP1 ILF2 DST LMAN1 IARS1 DIAPH3 FCHO2 TAF7 TOP1 MARCKS CEP55 ATP5F1C

3.23e-09708611239231216
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

TPM4 SERBP1 ILF2 DST RPLP1 RBBP6 IARS1 DAB2 IK SRRM2 TOP1 TOP2A ATP5F1C

8.38e-09949611336574265
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

TPM4 TAF3 SERBP1 ILF2 AKAP9 RPLP1 TMEM237 PHF3 SEC62 SRSF11 CHD1L CPSF2 PSMA8 TOP1 MARCKS

1.02e-081371611536244648
Pubmed

Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.

ORC2 SERBP1 DST RPLP1 RBBP6 PHF3 SRSF11 IK SRRM2 UTRN

1.81e-08506611030890647
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

TAF3 SERBP1 ILF2 ACAT1 RBBP6 PHF3 CHD1L KAT2A CPSF2 IK TAF7 TOP1 TOP2A

1.83e-081014611332416067
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

TPM4 SERBP1 ILF2 DST RPLP1 RBBP6 PHF3 IARS1 IK TOP1 TOP2A MARCKS CEP55 ATP5F1C

2.78e-081257611436526897
Pubmed

A High-Density Human Mitochondrial Proximity Interaction Network.

TPM4 ILF2 DST LMAN1 AKAP9 CENPE ACAT1 DIAPH3 SRRM2 SUCO TOP1 MRPL1 TOP2A SDHB ATP5F1C

3.25e-081496611532877691
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

TPM4 DMXL2 TAF3 ILF2 DST RBBP6 DNM3 SRSF11 CPSF2 IK SRRM2 TOP1 MARCKS

3.92e-081082611338697112
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

ILF2 DST LMAN1 ACAT1 RBBP6 IARS1 SEC62 SRSF11 PLCB4 DIAPH3 SRRM2 TOP1 MARCKS ATP5F1C

4.10e-081297611433545068
Pubmed

RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

SERBP1 ILF2 RPLP1 RBBP6 SRSF11 CPSF2 IK SRRM2 TOP1 MRPL1 TOP2A

4.10e-08713611129802200
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

ORC2 SRSF11 CHD1L DIAPH3 CPSF2 IK RNF17 SRRM2 TOP1 TOP2A

6.68e-08582611020467437
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

SERBP1 ILF2 RPLP1 IARS1 CPSF2 IK SRRM2 TOP1 TOP2A ATP5F1C

9.58e-08605611028977666
Pubmed

Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.

TPM4 SERBP1 ILF2 RPLP1 CHD1L SRRM2 TOP1 TOP2A CEP55 ATP5F1C

1.31e-07626611033644029
Pubmed

Human transcription factor protein interaction networks.

TPM4 TAF3 ILF2 DST ZSCAN21 RBBP6 IARS1 AUTS2 KAT2A CPSF2 SRRM2 TOP1 MRPL1 ATP5F1C

1.35e-071429611435140242
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

TPM4 SERBP1 DST CENPE FAM186A SRRM2 TOP2A

1.83e-0723461736243803
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

ILF2 DST ACAT1 IARS1 SRSF11 CPSF2 IK SRRM2 UTRN TOP1 TOP2A ATP5F1C

1.84e-071024611224711643
Pubmed

UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.

SERBP1 ILF2 COX16 IARS1 SPAG17 SRRM2 TOP1 CEP55 ATP5F1C

1.87e-0749161936273042
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

SERBP1 ILF2 DST RPLP1 ACAT1 PHF3 IK SRRM2 UTRN TOP1

1.94e-07653611022586326
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

SERBP1 ILF2 AKAP9 RBBP6 PHF3 IARS1 SRSF11 IK SRRM2 TOP1 TOP2A SDHB ATP5F1C

2.01e-071247611327684187
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

DMXL2 ILF2 LMAN1 AKAP9 TMEM237 ANKRD11 DIAPH3 DNAJB8 SRRM2 SUCO MRPL1 MARCKS SDHB CEP55

2.19e-071487611433957083
Pubmed

Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.

TPM4 SERBP1 DST RPLP1 IARS1 CHD1L UTRN TOP1 TOP2A

4.03e-0753861928524877
Pubmed

The TFIID components human TAF(II)140 and Drosophila BIP2 (TAF(II)155) are novel metazoan homologues of yeast TAF(II)47 containing a histone fold and a PHD finger.

TAF3 KAT2A TAF7

4.28e-07961311438666
Pubmed

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.

ILF2 ACAT1 IARS1 SRSF11 CPSF2 IK SRRM2 PSMA8 TOP1 TOP2A

4.38e-07714611028302793
Pubmed

ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.

TPM4 SERBP1 LMAN1 IARS1 DAB2 SRRM2 UTRN

4.56e-0726861733024031
Pubmed

Insights into the ubiquitin-proteasome system of human embryonic stem cells.

TPM4 SERBP1 ANKRD11 SRSF11 CPSF2 TOP1 ATP5F1C

4.68e-0726961729511261
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

TAF3 SERBP1 RBBP6 PHF3 DIAPH3 IK TAF7 TOP2A CEP55

4.77e-0754961938280479
Pubmed

A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells.

ORC2 TAF3 RBBP6 PHF3 SULT1C3 ANKRD11 CEP55 ATP5F1C

7.00e-0741961828700943
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

TPM4 SERBP1 ILF2 RPLP1 IARS1 DIAPH3 IK SRRM2 TOP1 TOP2A MARCKS SDHB ATP5F1C

8.41e-071415611328515276
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

SERBP1 ILF2 LMAN1 RPLP1 ACAT1 IARS1 IK SRRM2 TOP1 TOP2A MARCKS SDHB ATP5F1C

9.10e-071425611330948266
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

ORC2 ILF2 LMAN1 TMEM237 RBBP6 PHF3 IARS1 SEC62 AUTS2 SRRM2 TOP1 TOP2A

1.01e-061203611229180619
Pubmed

SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.

ILF2 LMAN1 ACAT1 IARS1 IK SRRM2 TOP1 TOP2A ATP5F1C

1.10e-0660761939147351
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

SERBP1 ILF2 DST AKAP9 ACAT1 IARS1 SPAG17 UTRN TOP1 ATP5F1C

1.33e-06807611030575818
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

SERBP1 DST COX16 RBBP6 PHF3 ANKRD11 KAT2A CPSF2 IK UTRN MARCKS CEP55 ATP5F1C

1.58e-061497611331527615
Pubmed

CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma.

TPM4 SERBP1 LMAN1 RPLP1 ANKRD11 MARCKS SDHB ATP5F1C

1.60e-0646861836042349
Pubmed

A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.

ILF2 DST PHF3 DAB2 CPSF2 FCHO2 IK SRRM2

1.70e-0647261838943005
Pubmed

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

SERBP1 ILF2 RBBP6 PHF3 IARS1 SRSF11 IK SRRM2 TOP1 TOP2A

2.04e-06847611035850772
Pubmed

Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.

TPM4 SERBP1 ILF2 RPLP1 IARS1 DNM3 UTRN TOP1 SDHB ATP5F1C

2.04e-06847611035235311
Pubmed

Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.

SERBP1 ILF2 ACAT1 RBBP6 IARS1 SRRM2 TOP2A SDHB ATP5F1C

2.31e-0666561930457570
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

SERBP1 RPLP1 RBBP6 PHF3 DAB2 FCHO2 SRRM2 TOP2A

2.72e-0650361816964243
Pubmed

The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.

DAB2 FCHO2 SRRM2 UTRN TOP2A

2.80e-0612561529467281
Pubmed

The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells.

NOD1 CENPE RASA4 RASA4B PLCB4 CEP55

2.98e-0622761626410627
Pubmed

DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride.

TOP1 TOP2A

3.03e-06261230132517
Pubmed

Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers.

TOP1 TOP2A

3.03e-06261225777966
Pubmed

CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway.

RASA4 RASA4B

3.03e-06261211448776
Pubmed

Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel.

TOP1 TOP2A

3.03e-06261224130054
Pubmed

Inhibition of DNA topoisomerases I and II by G3 PAMAM-NH2 dendrimer-modified digoxin and proscillaridin A conjugates in a cell free system.

TOP1 TOP2A

3.03e-06261221229879
Pubmed

Implications of Topoisomerase (TOP1 and TOP2α) Expression in Patients With Breast Cancer.

TOP1 TOP2A

3.03e-06261233144457
Pubmed

Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases.

TOP1 TOP2A

3.03e-06261232951576
Pubmed

An essential function for the calcium-promoted Ras inactivator in Fcgamma receptor-mediated phagocytosis.

RASA4 RASA4B

3.03e-06261216041389
Pubmed

β-Elemene Inhibits Cell Proliferation by Regulating the Expression and Activity of Topoisomerases I and IIα in Human Hepatocarcinoma HepG-2 Cells.

TOP1 TOP2A

3.03e-06261226221582
Pubmed

Analysis of expression and function of topoisomerase I and II during meiosis in male mice.

TOP1 TOP2A

3.03e-0626129094096
Pubmed

DNA topoisomerase I and II expression in drug resistant germ cell tumours.

TOP1 TOP2A

3.03e-06261212237772
Pubmed

Lack of topoisomerase copy number changes in patients with de novo and relapsed diffuse large B-cell lymphoma.

TOP1 TOP2A

3.03e-06261225931012
Pubmed

STK295900, a dual inhibitor of topoisomerase 1 and 2, induces G(2) arrest in the absence of DNA damage.

TOP1 TOP2A

3.03e-06261223349762
Pubmed

New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.

SERBP1 ILF2 DST RPLP1 SPAG17 SRRM2 TOP1 ATP5F1C

3.15e-0651361825798074
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

SERBP1 DST IARS1 SRSF11 CHD1L SRRM2 UTRN

3.24e-0636061733111431
Pubmed

SR protein kinases promote splicing of nonconsensus introns.

CENPE RBBP6 PHF3 SRSF11 CHD1L SRRM2 TOP1

3.30e-0636161726167880
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

ILF2 DST ACAT1 IARS1 CHD1L IK DCK SRRM2 UTRN TOP1 TOP2A ATP5F1C

3.41e-061353611229467282
Pubmed

Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion.

SERBP1 ILF2 LMAN1 ZSCAN21 SEC62 SRSF11 IK TAF7 CEP55

3.68e-0670461932994395
Pubmed

Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis.

SERBP1 ILF2 RNF17 TOP1 TOP2A ATP5F1C

3.72e-0623661636339263
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

SERBP1 ACAT1 PHF3 IARS1 DIAPH3 IK TAF7 TOP1 CEP55

4.61e-0672461936232890
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

TPM4 ORC2 SERBP1 DST RPLP1 RBBP6 UTRN TOP1 TOP2A MARCKS

4.85e-06934611033916271
Pubmed

Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.

ILF2 RPLP1 RBBP6 IARS1 SRSF11 IK SRRM2 TOP1 TOP2A

4.98e-0673161929298432
Pubmed

Defining the membrane proteome of NK cells.

ORC2 SERBP1 ILF2 LMAN1 CENPE TMEM237 IARS1 CPSF2 FERMT3 CEP55 ATP5F1C

5.24e-061168611119946888
Pubmed

SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.

SERBP1 RBBP6 CPSF2 IK TOP1 TOP2A

5.30e-0625161631076518
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

TPM4 SERBP1 DST RPLP1 SEC62 DAB2 SRSF11 FCHO2 MRPL1 TOP2A SDHB ATP5F1C

6.43e-061440611230833792
Pubmed

LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.

TPM4 SERBP1 ILF2 RPLP1 IARS1 KAT2A TOP1 ATP5F1C

7.72e-0658061835676659
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

ILF2 RPLP1 ACAT1 PHF3 SRSF11 IK SRRM2 TOP1 TOP2A ATP5F1C

8.00e-06989611036424410
Pubmed

Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease.

TPM4 SERBP1 ILF2 RPLP1 BIN3 SDHB CEP55

8.59e-0641861732552912
Pubmed

A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.

TPM4 SERBP1 ILF2 ACAT1 IARS1 IK TOP1 TOP2A ATP5F1C

8.91e-0678661929128334
Pubmed

The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas.

TOP1 TOP2A

9.07e-06361223214297
Pubmed

Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells.

TOP1 TOP2A

9.07e-06361222375014
Pubmed

CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane.

RASA4 RASA4B

9.07e-06361225637021
Pubmed

Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.

TOP1 TOP2A

9.07e-0636129049244
Pubmed

Topoisomerase expression in oral squamous cell carcinoma: relationship with cancer stem cells profiles and lymph node metastasis.

TOP1 TOP2A

9.07e-06361222672768
Pubmed

DNA topoisomerases participate in fragility of the oncogene RET.

TOP1 TOP2A

9.07e-06361224040417
Pubmed

Modulation of topoisomerase activities by tumor necrosis factor.

TOP1 TOP2A

9.07e-0636127842491
Pubmed

A bead-based approach for large-scale identification of in vitro kinase substrates.

SERBP1 RPLP1 SRSF11 SRRM2 TOP2A

1.02e-0516361522113938
Pubmed

Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.

ORC2 RBBP6 PHF3 IK TOP1 TOP2A

1.05e-0528361630585729
Pubmed

WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.

SERBP1 ILF2 RPLP1 IARS1 CPSF2 SRRM2 TOP1 TOP2A

1.18e-0561561831048545
Pubmed

Global landscape of HIV-human protein complexes.

LMAN1 AKAP9 IARS1 SEC62 IK SRRM2 TOP2A

1.53e-0545761722190034
Pubmed

Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.

TPM4 SERBP1 ILF2 DST UTRN PSMA8 TOP1 TOP2A ATP5F1C

1.57e-0584461925963833
Pubmed

Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.

ILF2 RPLP1 ACAT1 IARS1 SRRM2 TOP1 TOP2A ATP5F1C

1.59e-0564161836057605
Pubmed

Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation.

ILF2 DNM3 SRSF11 SRRM2 TOP2A

1.65e-0518061530110629
Pubmed

Ca2+-dependent monomer and dimer formation switches CAPRI Protein between Ras GTPase-activating protein (GAP) and RapGAP activities.

RASA4 RASA4B

1.81e-05461221460216
Pubmed

Identification of an alternatively spliced variant of Ca2+-promoted Ras inactivator as a possible regulator of RANKL shedding.

RASA4 RASA4B

1.81e-05461216234249
Pubmed

The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity by a direct interaction.

SRSF11 TOP1

1.81e-0546129756848
Pubmed

Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.

ORC2 SERBP1 ILF2 RPLP1 ACAT1 IARS1 CPSF2 PSMA8 MRPL1 SDHB ATP5F1C

1.83e-051335611129229926
Pubmed

SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.

SERBP1 RPLP1 RBBP6 IARS1 SRSF11 SRRM2 SDHB ATP5F1C

1.85e-0565561835819319
Pubmed

Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.

TPM4 DST ACAT1 IARS1 UTRN

2.20e-0519161533762435
Pubmed

Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7).

ILF2 RBBP6 TOP2A

2.23e-053161326678539
Pubmed

Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo.

LMAN1 ZSCAN21 SEC62 CPSF2 TAF7 TOP1

2.33e-0532661617015433
Pubmed

Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.

ILF2 ACAT1 IARS1 TOP1 TOP2A SDHB FERMT3

2.42e-0549161722623428
Pubmed

ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.

SERBP1 DNM3 SUCO TOP1 TOP2A MARCKS

2.50e-0533061633301849
Pubmed

Chemical Crosslinking Mass Spectrometry Analysis of Protein Conformations and Supercomplexes in Heart Tissue.

TPM4 NOD1 DST ACAT1 SDHB ATP5F1C

2.54e-0533161629199018
InteractionSMC5 interactions

ORC2 TAF3 SERBP1 ILF2 ZSCAN21 ACAT1 RBBP6 PHF3 ANKRD11 SRSF11 IK SRRM2 TOP1 MRPL1 TOP2A SDHB ATP5F1C

3.98e-0910006117int:SMC5
InteractionNR2C2 interactions

ORC2 TAF3 ILF2 LMAN1 RPLP1 ACAT1 RBBP6 IARS1 SRSF11 CHD1L CPSF2 DCK SRRM2 PSMA8 TOP1 MRPL1 TOP2A FERMT3 ATP5F1C

1.61e-0814036119int:NR2C2
InteractionATG16L1 interactions

TPM4 SERBP1 ILF2 NOD1 RPLP1 ACAT1 RBBP6 DIAPH3 CPSF2 IK TAF7 BIN3 TOP1 TOP2A FERMT3 CEP55 ATP5F1C

3.63e-0811616117int:ATG16L1
InteractionCIT interactions

TPM4 ORC2 SERBP1 ILF2 LMAN1 AKAP9 RPLP1 ACAT1 RBBP6 IARS1 CPSF2 IK SPAG17 SRRM2 TOP1 TOP2A SDHB ATP5F1C

1.60e-0714506118int:CIT
InteractionKCNA3 interactions

SERBP1 ILF2 DST LMAN1 RBBP6 PHF3 IARS1 DIAPH3 FCHO2 TAF7 TOP1 MARCKS CEP55 ATP5F1C

2.42e-078716114int:KCNA3
InteractionH2BC12 interactions

CYLC1 SERBP1 DST CENPE PHF3 ANKRD11 CHD1L SPAG17 TOP2A

5.07e-07322619int:H2BC12
InteractionRAD18 interactions

ORC2 SERBP1 RBBP6 IARS1 CPSF2 IK SRRM2 UTRN TOP1 TOP2A

1.04e-064576110int:RAD18
InteractionECT2 interactions

TPM4 SERBP1 ILF2 DST RPLP1 IARS1 CPSF2 SRRM2 TOP1 MRPL1 TOP2A CEP55 ATP5F1C

1.97e-068876113int:ECT2
InteractionKIF20A interactions

TPM4 SERBP1 ILF2 RPLP1 CENPE RBBP6 IARS1 CPSF2 IK SRRM2 UTRN TOP1 TOP2A ATP5F1C

2.30e-0610526114int:KIF20A
InteractionXRCC6 interactions

ORC2 SERBP1 ILF2 RPLP1 RBBP6 PHF3 CHD1L KAT2A IK SRRM2 TOP1 TOP2A MARCKS

3.23e-069286113int:XRCC6
InteractionHECTD1 interactions

SERBP1 ILF2 CENPE RBBP6 PHF3 ANKRD11 DNM3 CPSF2 IK UTRN TOP1 TOP2A ATP5F1C

6.13e-069846113int:HECTD1
InteractionRHOB interactions

SPAG1 ILF2 LMAN1 TMEM237 ACAT1 DAB2 PLCB4 DIAPH3 FCHO2 UTRN MARCKS CEP55

6.74e-068406112int:RHOB
InteractionCDC5L interactions

ORC2 ILF2 DST AKAP9 RBBP6 CHD1L CPSF2 IK RNF17 SRRM2 TOP1 TOP2A

8.06e-068556112int:CDC5L
InteractionUFL1 interactions

SERBP1 ILF2 LMAN1 RPLP1 ACAT1 IARS1 SEC62 SRSF11 CPSF2 IK SRRM2 TOP1 ATP5F1C

1.01e-0510316113int:UFL1
InteractionIQGAP1 interactions

TPM4 SERBP1 ILF2 DST DAB2 ANKRD11 SRRM2 MARCKS SDHB ATP5F1C

1.02e-055916110int:IQGAP1
InteractionRBM8A interactions

ORC2 SERBP1 ILF2 RPLP1 IARS1 SRRM2 UTRN TOP1 MARCKS

1.18e-05473619int:RBM8A
InteractionTNIP1 interactions

TPM4 SERBP1 ILF2 DST RARG RPLP1 RBBP6 IARS1 DAB2 IK SRRM2 TOP1 TOP2A ATP5F1C

1.23e-0512176114int:TNIP1
InteractionSIRT7 interactions

SERBP1 ILF2 DST RPLP1 ACAT1 PHF3 IK SRRM2 UTRN TOP1 TOP2A

1.25e-057446111int:SIRT7
InteractionPAFAH1B1 interactions

AP4E1 CENPE ACAT1 IARS1 SRRM2 TOP2A ATP5F1C

1.26e-05258617int:PAFAH1B1
InteractionDDX23 interactions

TAF3 RBBP6 PHF3 ANKRD11 SRSF11 IK SRRM2 TOP1 TOP2A

1.32e-05480619int:DDX23
InteractionSNRPA interactions

ILF2 RBBP6 PHF3 SRSF11 CPSF2 IK SRRM2 TOP1 TOP2A

1.37e-05482619int:SNRPA
InteractionRAC1 interactions

TPM4 DST LMAN1 TMEM237 DAB2 PLCB4 DIAPH3 FCHO2 TAF7 UTRN TOP2A MARCKS CEP55

1.40e-0510636113int:RAC1
InteractionRAC3 interactions

LMAN1 TMEM237 ANKRD11 PLCB4 DIAPH3 FCHO2 TAF7 UTRN MARCKS CEP55

1.53e-056196110int:RAC3
InteractionPOLR1G interactions

TAF3 ZSCAN21 PHF3 ANKRD11 IK SRRM2 TOP1 TOP2A ATP5F1C

1.53e-05489619int:POLR1G
InteractionDDRGK1 interactions

SERBP1 ILF2 LMAN1 RPLP1 ACAT1 IARS1 SEC62 SRSF11 IK SRRM2 TOP1 TOP2A MARCKS ATP5F1C

1.65e-0512496114int:DDRGK1
InteractionCDK7 interactions

TPM4 SERBP1 LMAN1 ANKRD11 TAF7 TOP2A MARCKS SDHB ATP5F1C

1.86e-05501619int:CDK7
InteractionCEBPB interactions

TPM4 SERBP1 ILF2 AKAP9 RPLP1 ACAT1 IARS1 SRSF11 KAT2A IK TAF7 SRRM2 TOP1 TOP2A SDHB

1.89e-0514436115int:CEBPB
InteractionCDK2 interactions

TPM4 ORC2 SERBP1 ILF2 DST IARS1 KAT2A TAF7 SRRM2 TOP1 MARCKS

2.01e-057836111int:CDK2
InteractionACE2 interactions

TPM4 SERBP1 ILF2 RPLP1 ACAT1 IARS1 DAB2 DIAPH3 SRRM2 TOP1 TOP2A MARCKS ATP5F1C

2.13e-0511066113int:ACE2
InteractionMAPRE1 interactions

TPM4 DST AKAP9 RPLP1 CENPE DAB2 DIAPH3 SRRM2 CEP55

2.27e-05514619int:MAPRE1
InteractionHNRNPUL2 interactions

ILF2 RBBP6 IARS1 SRRM2 TOP1 TOP2A SDHB

2.73e-05291617int:HNRNPUL2
InteractionPRC1 interactions

ORC2 SERBP1 ILF2 AKAP9 RPLP1 CENPE RBBP6 IK SRRM2 TOP1 TOP2A FERMT3

2.92e-059736112int:PRC1
InteractionRHOF interactions

TPM4 LMAN1 TMEM237 DAB2 PLCB4 DIAPH3 FCHO2 UTRN MARCKS CEP55

3.12e-056736110int:RHOF
InteractionGATA4 interactions

TPM4 TAF3 ILF2 IK SRRM2 TOP1 TOP2A ATP5F1C

3.20e-05411618int:GATA4
InteractionSNRNP70 interactions

TPM4 SERBP1 ILF2 RPLP1 RBBP6 SRSF11 CPSF2 IK SRRM2 TOP1 MRPL1 TOP2A

3.26e-059846112int:SNRNP70
InteractionRBM14 interactions

ILF2 AKAP9 AUTS2 SRSF11 CPSF2 IK TOP1 SDHB CEP55

4.02e-05553619int:RBM14
InteractionACTC1 interactions

ORC2 SERBP1 DST RPLP1 RBBP6 PHF3 SRSF11 IK SRRM2 UTRN

4.05e-056946110int:ACTC1
InteractionTOP1 interactions

ILF2 RBBP6 PHF3 SRSF11 CPSF2 IK SRRM2 BIN3 TOP1 TOP2A

4.15e-056966110int:TOP1
InteractionMYCN interactions

SERBP1 ILF2 RPLP1 RBBP6 PHF3 SRSF11 CPSF2 IK SRRM2 TOP1 MRPL1 MARCKS SDHB ATP5F1C

4.72e-0513736114int:MYCN
InteractionTRPV1 interactions

SERBP1 DST IARS1 DAB2 FCHO2

4.78e-05131615int:TRPV1
InteractionSNRPC interactions

SERBP1 ILF2 RBBP6 PHF3 CPSF2 IK SRRM2 TOP1

5.18e-05440618int:SNRPC
InteractionRHOD interactions

TPM4 LMAN1 TMEM237 DAB2 PLCB4 DIAPH3 FCHO2 UTRN MARCKS

5.22e-05572619int:RHOD
InteractionHNRNPU interactions

SERBP1 ILF2 LMAN1 RPLP1 SEC62 SRSF11 IK SRRM2 TOP1 MRPL1 TOP2A MARCKS

5.33e-0510356112int:HNRNPU
InteractionRHOQ interactions

DST TMEM237 PLCB4 DIAPH3 FCHO2 UTRN MARCKS CEP55

5.35e-05442618int:RHOQ
InteractionZNF330 interactions

ORC2 TAF3 ZSCAN21 PHF3 ANKRD11 IK TOP1 TOP2A

5.70e-05446618int:ZNF330
InteractionKTN1 interactions

SERBP1 DST LMAN1 CENPE TMEM237 SEC62 TOP2A

6.17e-05331617int:KTN1
InteractionCSTF3 interactions

SERBP1 DST RBBP6 CPSF2 TOP1

6.33e-05139615int:CSTF3
InteractionPPIA interactions

TAF3 SERBP1 ILF2 DST PHF3 DAB2 CPSF2 FCHO2 IK SRRM2 TOP2A

6.34e-058886111int:PPIA
InteractionCTCF interactions

TAF3 SERBP1 RPLP1 ZSCAN21 IARS1 CHD1L TOP2A ATP5F1C

7.18e-05461618int:CTCF
InteractionTERF2 interactions

ORC2 DST SRSF11 SRRM2 UTRN TOP1 TOP2A

7.30e-05340617int:TERF2
InteractionZCCHC10 interactions

TAF3 RBBP6 SRSF11 IK TAF7 SRRM2

7.85e-05236616int:ZCCHC10
InteractionRHOG interactions

LMAN1 TMEM237 ACAT1 PLCB4 DIAPH3 FCHO2 TAF7 MRPL1 MARCKS CEP55 ATP5F1C

7.89e-059106111int:RHOG
InteractionPCNT interactions

DMXL2 DST AKAP9 DNM3 UTRN CEP55

8.81e-05241616int:PCNT
InteractionHDAC6 interactions

TPM4 SERBP1 ILF2 RPLP1 IARS1 KAT2A DIAPH3 DNAJB8 SRRM2 TOP1 ATP5F1C

9.49e-059296111int:HDAC6
InteractionWDR5 interactions

SERBP1 ILF2 ACAT1 IARS1 AUTS2 KAT2A CPSF2 TAF7 UTRN MARCKS CEP55 ATP5F1C

9.65e-0511016112int:WDR5
InteractionAGR2 interactions

SERBP1 ILF2 DST AKAP9 ACAT1 IARS1 ANKRD11 SPAG17 UTRN TOP1 ATP5F1C

9.95e-059346111int:AGR2
InteractionMECP2 interactions

TPM4 DMXL2 TAF3 ILF2 DST RBBP6 DNM3 SRSF11 CPSF2 IK SRRM2 TOP1 MARCKS

1.02e-0412876113int:MECP2
InteractionGTF3C6 interactions

CPSF2 SRRM2 BIN3

1.12e-0431613int:GTF3C6
InteractionRHOJ interactions

LMAN1 TMEM237 PLCB4 DIAPH3 FCHO2 UTRN MARCKS CEP55 ATP5F1C

1.13e-04633619int:RHOJ
InteractionHNRNPC interactions

SERBP1 ILF2 AKAP9 RBBP6 DAB2 AUTS2 SRRM2 TOP1 TOP2A

1.15e-04634619int:HNRNPC
InteractionRPL6 interactions

SERBP1 ILF2 DST RARG RPLP1 SRRM2 TOP1 MRPL1 TOP2A

1.19e-04637619int:RPL6
InteractionUBE2O interactions

SERBP1 ILF2 RPLP1 COX16 IARS1 SPAG17 SRRM2 TOP1 CEP55 ATP5F1C

1.19e-047906110int:UBE2O
InteractionCSNK2A1 interactions

SERBP1 DST RPLP1 ANKRD11 AUTS2 SRSF11 TAF7 SRRM2 TOP1 TOP2A MARCKS

1.22e-049566111int:CSNK2A1
InteractionBTF3 interactions

TPM4 SERBP1 ILF2 RPLP1 CHD1L SRRM2 TOP1 TOP2A CEP55 ATP5F1C

1.31e-047996110int:BTF3
InteractionCBX3 interactions

ORC2 ZSCAN21 RBBP6 PHF3 CHD1L DCK SRRM2 TOP1 TOP2A

1.32e-04646619int:CBX3
InteractionCDC42 interactions

LMAN1 RPLP1 TMEM237 IARS1 PLCB4 DIAPH3 FCHO2 TAF7 BIN3 UTRN MARCKS CEP55 ATP5F1C

1.35e-0413236113int:CDC42
InteractionGRM2 interactions

SERBP1 ILF2 LMAN1 TMEM237 IARS1 TOP2A ATP5F1C

1.48e-04381617int:GRM2
InteractionRHOH interactions

TPM4 DST LMAN1 TMEM237 DAB2 PLCB4 MARCKS CEP55

1.48e-04512618int:RHOH
InteractionBET1 interactions

DST LMAN1 TMEM237 IARS1 SEC62 MARCKS ATP5F1C

1.58e-04385617int:BET1
InteractionSNRPB interactions

ILF2 AKAP9 RBBP6 PHF3 IK SRRM2 TOP1 CEP55

1.58e-04517618int:SNRPB
InteractionRAC2 interactions

DST LMAN1 TMEM237 DAB2 PLCB4 DIAPH3 FCHO2 UTRN MARCKS

1.82e-04674619int:RAC2
InteractionSSRP1 interactions

ILF2 RBBP6 PHF3 ANKRD11 CHD1L SRRM2 TOP1 TOP2A MARCKS

2.05e-04685619int:SSRP1
InteractionCDK9 interactions

TPM4 SERBP1 ILF2 RPLP1 IARS1 TAF7 SRRM2 TOP1 ATP5F1C

2.05e-04685619int:CDK9
InteractionPPIE interactions

ILF2 AKAP9 SRSF11 IK SRRM2 TOP1

2.07e-04282616int:PPIE
InteractionATP5IF1 interactions

DST SPAG17 MARCKS SDHB ATP5F1C

2.08e-04179615int:ATP5IF1
InteractionCHMP4C interactions

TPM4 SERBP1 ILF2 LMAN1 RPLP1 IARS1 SRSF11 TOP1 TOP2A

2.10e-04687619int:CHMP4C
InteractionRNF113A interactions

SERBP1 RPLP1 RBBP6 IARS1 SRSF11 IK SRRM2 SDHB ATP5F1C

2.21e-04692619int:RNF113A
InteractionTEX14 interactions

CENPE RNF17 CEP55

2.23e-0439613int:TEX14
InteractionRBBP5 interactions

CPSF2 TAF7 SRRM2 TOP1 TOP2A FERMT3

2.28e-04287616int:RBBP5
InteractionH2BC21 interactions

CYLC1 ORC2 SERBP1 PHF3 CHD1L KAT2A SRRM2 TOP1 TOP2A

2.31e-04696619int:H2BC21
InteractionEP300 interactions

TPM4 ORC2 ILF2 RARG RBBP6 SEC62 DNM3 AUTS2 SRSF11 KAT2A IK SRRM2 TOP2A

2.37e-0414016113int:EP300
InteractionTERF2IP interactions

RBBP6 PHF3 ANKRD11 SRSF11 IK SRRM2 TOP1 TOP2A

2.47e-04552618int:TERF2IP
InteractionDHX8 interactions

SERBP1 RBBP6 SRSF11 IK SRRM2 TOP1

2.50e-04292616int:DHX8
InteractionDBN1 interactions

TPM4 DST IARS1 DAB2 FCHO2 MARCKS CEP55

2.57e-04417617int:DBN1
InteractionRBM39 interactions

ILF2 RPLP1 ACAT1 IARS1 SRSF11 CPSF2 IK SRRM2 PSMA8 TOP1 TOP2A

2.59e-0410426111int:RBM39
InteractionSOAT1 interactions

SERBP1 ILF2 LMAN1 IARS1 SEC62 ATP5F1C

2.64e-04295616int:SOAT1
InteractionZC3H18 interactions

ILF2 RPLP1 RBBP6 IARS1 SRSF11 IK SRRM2 TOP1 TOP2A FERMT3

2.78e-048776110int:ZC3H18
InteractionNDUFB10 interactions

TPM4 SERBP1 DNAJB8 SDHB ATP5F1C

3.02e-04194615int:NDUFB10
InteractionDISC1 interactions

TPM4 AP4E1 DST AKAP9 DCK UTRN TOP1

3.05e-04429617int:DISC1
InteractionCLK2 interactions

ZSCAN21 RBBP6 SRSF11 CPSF2 SRRM2

3.09e-04195615int:CLK2
InteractionNIFK interactions

TAF3 SERBP1 ZSCAN21 RBBP6 PHF3 ANKRD11 IK

3.14e-04431617int:NIFK
InteractionRAB35 interactions

SPAG1 SERBP1 DST LMAN1 DIAPH3 FCHO2 UTRN MARCKS

3.18e-04573618int:RAB35
InteractionCLK4 interactions

RBBP6 RASA4 SRRM2

3.20e-0444613int:CLK4
InteractionEFTUD2 interactions

TPM4 SERBP1 ILF2 RPLP1 IARS1 DIAPH3 CPSF2 IK SRRM2 TOP1 TOP2A MARCKS ATP5F1C

3.30e-0414496113int:EFTUD2
InteractionPIH1D1 interactions

TPM4 SERBP1 ILF2 LMAN1 RPLP1 IARS1 SRRM2 MARCKS SDHB

3.31e-04731619int:PIH1D1
InteractionNEK4 interactions

SERBP1 ILF2 DST RPLP1 SPAG17 SRRM2 TOP1 ATP5F1C

3.53e-04582618int:NEK4
InteractionNDC80 interactions

AKAP9 CENPE PHF3 DIAPH3 TOP1 CEP55

3.56e-04312616int:NDC80
InteractionARF6 interactions

AP4E1 LMAN1 TMEM237 KAT2A FCHO2 MARCKS MSMB ATP5F1C

3.61e-04584618int:ARF6
InteractionNCAPH interactions

SERBP1 ILF2 RPLP1 CENPE IARS1 TOP2A

3.75e-04315616int:NCAPH
InteractionH2BC9 interactions

CYLC1 SERBP1 DST SRSF11 SPAG17 PSMA8 TOP2A

3.86e-04446617int:H2BC9
Cytoband1p31

SERBP1 SRSF11

3.59e-04216121p31
Cytoband10p15.1

TAF3 ATP5F1C

6.42e-042861210p15.1
Cytoband15q21.2

AP4E1 DMXL2

6.89e-042961215q21.2
CytobandEnsembl 112 genes in cytogenetic band chr10p14

TAF3 ATP5F1C

1.96e-0349612chr10p14
CytobandEnsembl 112 genes in cytogenetic band chr7q22

ZSCAN21 RASA4 RASA4B

3.14e-03219613chr7q22
GeneFamilyTopoisomerases

TOP1 TOP2A

5.43e-0563521050
GeneFamilyPleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing

RASA4 RASA4B

1.62e-0410352830
CoexpressionTABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING

SERBP1 ILF2 AKAP9 RPLP1 ACAT1 COX16 SEC62 ANKRD11 SRSF11 IK SRRM2 BIN3 TOP1 SDHB FERMT3

3.87e-0811446115MM3843
CoexpressionDESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP

ILF2 CENPE IARS1 DAB2 SUCO TOP2A MARCKS CEP55

9.08e-08242618M34034
CoexpressionMARTINEZ_RESPONSE_TO_TRABECTEDIN_DN

SERBP1 DCK SRRM2 TOP1 MRPL1 TOP2A CEP55

3.24e-06272617M15123
CoexpressionRODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP

TPM4 LMAN1 CENPE RBBP6 IARS1 DIAPH3 CPSF2 TOP1 TOP2A CEP55

5.92e-067216110M10237
CoexpressionDAZARD_RESPONSE_TO_UV_NHEK_DN

ORC2 DST AKAP9 PHF3 AUTS2 SUCO TOP2A

6.17e-06300617M8702
CoexpressionBUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS

AKAP9 SEC62 PLCB4 SRRM2

1.17e-0560614M40007
CoexpressionNAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP

TPM4 DMXL2 NOD1 ACAT1 COX16 RBBP6 IARS1 SEC62 DAB2 AUTS2 DCK ATP5F1C

1.98e-0512156112M41122
CoexpressionDAZARD_UV_RESPONSE_CLUSTER_G6

ORC2 PHF3 AUTS2 SUCO TOP2A

2.24e-05145615M1810
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

ORC2 DMXL2 DST AKAP9 CENPE PHF3 PLCB4 SUCO TOP1 TOP2A

2.61e-058566110M4500
CoexpressionMALONEY_RESPONSE_TO_17AAG_DN

ILF2 IARS1 SEC62 ATP5F1C

3.16e-0577614M1858
CoexpressionREICHERT_MITOSIS_LIN9_TARGETS

CENPE TOP2A CEP55

3.37e-0527613M2483
CoexpressionTRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL

ILF2 RPLP1 CENPE TMEM237 DIAPH3 DCK TOP2A MARCKS CEP55 ATP5F1C

3.67e-058916110M41654
CoexpressionREICHERT_MITOSIS_LIN9_TARGETS

CENPE TOP2A CEP55

3.77e-0528613MM1323
CoexpressionGSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP

SPAG1 NOD1 SPAG17 TOP2A MARCKS

3.81e-05162615M8883
CoexpressionYANAGIHARA_ESX1_TARGETS

DAB2 SRSF11 MARCKS

4.20e-0529613M1538
CoexpressionLAKE_ADULT_KIDNEY_C28_INTERSTITIUM

DST RPLP1 AUTS2 UTRN

4.89e-0586614M39247
CoexpressionLAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2

DST AUTS2 PLCB4 UTRN

4.89e-0586614M39248
CoexpressionLAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS

DST AKAP9 ANKRD11 UTRN TOP1

5.81e-05177615M39245
CoexpressionZHANG_BREAST_CANCER_PROGENITORS_UP

SERBP1 AKAP9 AUTS2 IK DCK TOP2A CEP55

6.56e-05434617M15150
CoexpressionTRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL

ILF2 DST CENPE ACAT1 DAB2 DIAPH3 DCK TOP2A CEP55 ATP5F1C

7.35e-059686110M41693
CoexpressionZHANG_BREAST_CANCER_PROGENITORS_UP

SERBP1 AKAP9 AUTS2 IK DCK TOP2A CEP55

8.00e-05448617MM1044
CoexpressionGSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP

DMXL2 SPAG1 TAF3 AUTS2 SUCO

8.97e-05194615M4221
CoexpressionBUSSLINGER_GASTRIC_ISTHMUS_CELLS

TPM4 SERBP1 DST CENPE TOP1 TOP2A MARCKS

9.18e-05458617M40010
CoexpressionLAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED

TPM4 PLCB4 UTRN

9.55e-0538613M39244
CoexpressionGSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP

RBBP6 DAB2 AUTS2 IK ATP5F1C

9.87e-05198615M5774
CoexpressionGSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN

CENPE ACAT1 IARS1 KAT2A TOP2A

1.01e-04199615M9422
CoexpressionGSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP

DMXL2 IK SRRM2 TOP2A MSMB

1.01e-04199615M5239
CoexpressionGSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN

RARG RNF17 UTRN CNGA1 TOP1

1.01e-04199615M8805
CoexpressionLAKE_ADULT_KIDNEY_C18_COLLECTING_DUCT_PRINCIPAL_CELLS_MEDULLA

TPM4 SERBP1 RPLP1 ACAT1 SEC62 ATP5F1C

1.03e-04322616M39237
CoexpressionGSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP

NOD1 CENPE ACAT1 DIAPH3 SDHB

1.03e-04200615M8075
CoexpressionGSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP

AKAP9 RASA4 KAT2A CPSF2 BIN3

1.03e-04200615M4021
CoexpressionGSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP

SPAG1 CENPE DIAPH3 TOP2A CEP55

1.03e-04200615M3577
CoexpressionHALLMARK_E2F_TARGETS

ORC2 CENPE DIAPH3 DCK TOP2A

1.03e-04200615M5925
CoexpressionLAKE_ADULT_KIDNEY_C19_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_MEDULLA

SERBP1 RPLP1 ACAT1 SEC62 TAF7 ATP5F1C

1.10e-04326616M39238
CoexpressionGAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS

TMEM237 DIAPH3 TOP2A CEP55

1.15e-04107614M39165
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

CENPE PHF3 IARS1 SEC62 SRSF11 DIAPH3 SUCO CEP55

1.35e-04656618M18979
CoexpressionPATIL_LIVER_CANCER

ILF2 TMEM237 IARS1 CPSF2 DCK SUCO TOP2A CEP55

1.41e-04660618M1195
CoexpressionHAY_BONE_MARROW_ERYTHROBLAST

ORC2 SERBP1 ILF2 CENPE TMEM237 ACAT1 IARS1 DIAPH3 IK TOP1 MRPL1

1.49e-0412716111M39197
CoexpressionDANG_BOUND_BY_MYC

AP4E1 NOD1 AKAP9 SEC62 SRSF11 CHD1L DCK SRRM2 TOP1 ATP5F1C

1.56e-0410616110M15774
CoexpressionOUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP

TPM4 IARS1 SDHB ATP5F1C

1.67e-04118614M12016
CoexpressionKAYO_AGING_MUSCLE_DN

RBBP6 TOP1 SDHB ATP5F1C

2.02e-04124614M17261
CoexpressionFAN_EMBRYONIC_CTX_NSC_2

ILF2 CENPE DIAPH3 TOP2A CEP55

2.11e-04233615M39036
CoexpressionFAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL

SERBP1 ILF2 RBBP6 IARS1 SRRM2 TOP1

2.53e-04380616M41703
CoexpressionJI_RESPONSE_TO_FSH_DN

SERBP1 TOP1 TOP2A

2.59e-0453613M17537
CoexpressionWANG_TUMOR_INVASIVENESS_UP

TAF3 SERBP1 SEC62 DAB2 CPSF2 MARCKS

2.68e-04384616M1865
CoexpressionODONNELL_TFRC_TARGETS_DN

CENPE DIAPH3 TOP2A CEP55

3.13e-04139614M6451
CoexpressionJOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP

TPM4 TOP2A MARCKS

3.21e-0457613M1120
CoexpressionCORDENONSI_YAP_CONSERVED_SIGNATURE

DAB2 TOP2A MARCKS

3.21e-0457613M2871
CoexpressionGSE21033_1H_VS_12H_POLYIC_STIM_DC_DN

RBBP6 PHF3 TAF7 MARCKS

3.30e-04141614M7720
CoexpressionWANG_TUMOR_INVASIVENESS_UP

TAF3 SERBP1 SEC62 DAB2 CPSF2 MARCKS

3.42e-04402616MM1248
CoexpressionMONTERO_THYROID_CANCER_POOR_SURVIVAL_UP

DIAPH3 CEP55

3.46e-0412612M11629
CoexpressionPUJANA_CHEK2_PCC_NETWORK

ILF2 CENPE RBBP6 IARS1 SRSF11 DCK TOP1 TOP2A

3.68e-04761618M11961
CoexpressionJOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP

TPM4 TOP2A MARCKS

3.73e-0460613MM1101
CoexpressionFISCHER_DREAM_TARGETS

ORC2 CENPE RBBP6 DIAPH3 DCK TOP1 TOP2A MARCKS CEP55

3.83e-04969619M149
CoexpressionINAMURA_LUNG_CANCER_SCC_UP

PSMA8 TOP2A

4.09e-0413612M1253
CoexpressionTABULA_MURIS_SENIS_LUNG_INTERMEDIATE_MONOCYTE_AGEING

RPLP1 FCHO2 SRRM2 MARCKS FERMT3 ATP5F1C

4.26e-04419616MM3768
CoexpressionLAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR

DST RPLP1 PLCB4 UTRN

4.39e-04152614M39243
CoexpressionGSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_UP

RPLP1 TOP1 TOP2A SDHB

4.72e-04155614M358
CoexpressionFAN_EMBRYONIC_CTX_MICROGLIA_1

CENPE DIAPH3 TOP2A CEP55

4.72e-04155614M39041
CoexpressionRHODES_CANCER_META_SIGNATURE

ILF2 IARS1 TOP2A

4.73e-0465613M1345
CoexpressionGOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP

RBBP6 DCK TOP1

5.40e-0468613M1373
CoexpressionFAN_OVARY_CL11_MURAL_GRANULOSA_CELL

DST AKAP9 RBBP6 ANKRD11 SRSF11 MARCKS

5.77e-04444616M41713
CoexpressionBASAKI_YBX1_TARGETS_UP

TPM4 ILF2 PLCB4 DIAPH3 CEP55

6.11e-04294615M14985
CoexpressionSARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP

CENPE DCK TOP2A CEP55

6.11e-04166614M4288
CoexpressionAIZARANI_LIVER_C20_LSECS_3

RBBP6 DAB2 ANKRD11 TOP1 MARCKS

6.20e-04295615M39121
CoexpressionGOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP

RBBP6 DCK TOP1

6.38e-0472613MM1131
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

ORC2 DST AKAP9 CENPE PHF3 TOP2A

7.43e-04466616M13522
CoexpressionBENPORATH_CYCLING_GENES

DMXL2 ILF2 CENPE SEC62 TOP1 TOP2A CEP55

7.50e-04648617M8156
CoexpressionGSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP

DST CENPE TOP2A CEP55

7.61e-04176614M2981
CoexpressionBORCZUK_MALIGNANT_MESOTHELIOMA_UP

SERBP1 ILF2 DCK TOP2A SDHB

7.76e-04310615M10236
CoexpressionCUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE

DST LMAN1 AKAP9 SUCO

8.10e-04179614M39308
CoexpressionCHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP

CENPE TOP2A MARCKS CEP55

8.10e-04179614M3268
CoexpressionGSE14415_INDUCED_VS_NATURAL_TREG_DN

TPM4 LMAN1 TOP2A CEP55

8.44e-04181614M2969
CoexpressionFAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL

TPM4 LMAN1 RBBP6 SRSF11 ATP5F1C

8.69e-04318615M41707
CoexpressionCHOI_ATL_CHRONIC_VS_ACUTE_DN

SERBP1 IARS1

8.88e-0419612M609
CoexpressionGSE6259_33D1_POS_DC_VS_CD4_TCELL_UP

CENPE IARS1 UTRN TOP2A

8.98e-04184614M6756
CoexpressionMENON_FETAL_KIDNEY_3_STROMAL_CELLS

TPM4 DST MARCKS

8.99e-0481613M39253
CoexpressionBLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN

CENPE DIAPH3 TOP2A CEP55

9.53e-04187614M34027
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

SERBP1 NOD1 DST LMAN1 RBBP6 DAB2 DNM3 BIN3 MARCKS

9.63e-041102619M2369
CoexpressionMENON_FETAL_KIDNEY_10_IMMUNE_CELLS

RPLP1 DAB2 TOP1

9.65e-0483613M39260
CoexpressionTRAVAGLINI_LUNG_BASAL_CELL

DST RPLP1 TMEM237 MARCKS

9.72e-04188614M41651
CoexpressionLINDGREN_BLADDER_CANCER_CLUSTER_3_UP

CENPE SEC62 DAB2 TOP2A CEP55

9.98e-04328615M854
CoexpressionGSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN

CENPE PLCB4 TOP2A CEP55

1.03e-03191614M9977
CoexpressionMACLACHLAN_BRCA1_TARGETS_UP

TOP1 TOP2A

1.09e-0321612M17772
CoexpressionGSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP

AKAP9 CENPE ACAT1 SUCO

1.09e-03194614M3540
CoexpressionBUSSLINGER_DUODENAL_TRANSIT_AMPLIFYING_CELLS

RPLP1 TOP2A MARCKS ATP5F1C

1.09e-03194614M40026
CoexpressionMORI_PRE_BI_LYMPHOCYTE_UP

RASA4 RASA4B TOP2A

1.11e-0387613MM1136
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

SERBP1 NOD1 DST LMAN1 RBBP6 DAB2 DNM3 BIN3 MARCKS

1.11e-031124619MM1070
CoexpressionGSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN

ILF2 ANKRD11 BIN3 TOP2A

1.11e-03195614M3145
CoexpressionGSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP

SERBP1 ILF2 IARS1 FCHO2

1.13e-03196614M3148
CoexpressionGSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN

NOD1 DST DAB2 ATP5F1C

1.16e-03197614M5786
CoexpressionGSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP

TPM4 DMXL2 MARCKS FERMT3

1.16e-03197614M8676
CoexpressionGSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP

ORC2 RARG ZSCAN21 CPSF2

1.18e-03198614M7875
CoexpressionNAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP

CENPE TOP2A CEP55

1.18e-0389613M2761
CoexpressionGSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP

SERBP1 SEC62 KAT2A CPSF2

1.20e-03199614M3328
CoexpressionGSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN

NOD1 KAT2A PSMA8 SDHB

1.20e-03199614M3313
CoexpressionGSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN

SPAG1 RPLP1 TOP2A CEP55

1.20e-03199614M8029
CoexpressionHALLMARK_MITOTIC_SPINDLE

DST CENPE TOP2A MARCKS

1.20e-03199614M5893
CoexpressionGSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP

TMEM237 IARS1 DIAPH3 TOP2A

1.20e-03199614M8277
CoexpressionGSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP

ORC2 CENPE TOP2A CEP55

1.20e-03199614M8266
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500_K3

TPM4 ORC2 SERBP1 AKAP9 CENPE RBBP6 PHF3 AUTS2 SRSF11 CPSF2 TOP1 TOP2A MARCKS

4.71e-0512576113facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlasJC_iEC_top-relative-expression-ranked_2500_k-means-cluster#5

RPLP1 CENPE RBBP6 SEC62 DNM3 TAF7 TOP1 TOP2A SDHB FERMT3

5.56e-057596110JC_iEC_2500_K5
CoexpressionAtlasFacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1

SERBP1 DST AKAP9 CENPE IARS1 ANKRD11 FCHO2 TOP1

5.63e-05469618Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000

SERBP1 DST RBBP6 PHF3 DNM3 AUTS2 CPSF2 TAF7 SUCO UTRN

6.20e-057696110gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500

CENPE ANKRD11 SRSF11 UTRN TOP1

7.12e-05150615gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlasdev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000

ORC2 CHD1L DIAPH3 DCK PSMA8 CEP55

9.63e-05258616gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500

CENPE SRSF11 DCK UTRN TOP1

9.94e-05161615gudmap_developingGonad_e12.5_ovary_k3_500
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500

CENPE ANKRD11 SRSF11 RNF17 UTRN CNGA1 TOP1

1.52e-04403617gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5

TAF3 AKAP9 CENPE SRSF11 TOP1

1.95e-04186615Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500

TPM4 ORC2 SERBP1 AKAP9 CENPE RBBP6 PHF3 AUTS2 SRSF11 CPSF2 TOP1 TOP2A MARCKS

2.12e-0414596113facebase_RNAseq_e10.5_Emin_LatNas_2500
ToppCelldroplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AKAP9 ANKRD11 PLCB4 FCHO2 TAF7 SUCO UTRN TOP1

2.50e-10194618e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AKAP9 ANKRD11 PLCB4 FCHO2 TAF7 SRRM2 UTRN

4.91e-0917861701dafd19de04eff459253eaa9a35debf8f3deedf
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RPLP1 CENPE ANKRD11 DIAPH3 SRRM2 TOP2A CEP55

6.66e-0918661715ab6666748a641226e42e6ca6eeaf186a501c95
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RPLP1 CENPE ANKRD11 DIAPH3 SRRM2 TOP2A CEP55

6.66e-091866174ed1b97e2552f3c4134f25665d7513498ffac16c
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

TAF3 AKAP9 CENPE RBBP6 SRSF11 SRRM2 TOP2A

9.90e-091976170fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCellSigmoid-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass

DMXL2 CENPE DAB2 ANKRD11 TOP2A MARCKS CEP55

1.10e-08200617372fe9018481a4e9ac6ab3af43705a48238c4376
ToppCellCOVID-19|World / Disease, condition lineage and cell class

TPM4 RBBP6 PHF3 ANKRD11 SRRM2 UTRN TOP1

1.10e-082006177dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CENPE TMEM237 DIAPH3 DCK TOP2A CEP55

1.43e-0717461672df66319f6efbd88ecf439013d97409fbf3cb52
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CENPE TMEM237 DIAPH3 DCK TOP2A CEP55

1.43e-07174616c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235
ToppCelldroplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CENPE DAB2 DIAPH3 PSMA8 TOP2A CEP55

1.92e-07183616e91f00b75d43ee6293fdd4a129b789cd95f8d11a
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

ILF2 CENPE DIAPH3 TOP2A MARCKS CEP55

2.05e-071856166aeae77a087d695b1e58c5f63265e7113aa2e343
ToppCelldroplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AKAP9 SEC62 ANKRD11 SRSF11 SRRM2 TOP1

2.25e-07188616d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCellH1299-infected|H1299 / Cell line, Condition and Strain

AKAP9 CENPE ANKRD11 SRSF11 SRRM2 TOP2A

2.55e-071926169cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCelldroplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DMXL2 CENPE DAB2 DCK TOP2A CEP55

2.79e-07195616c1435e61e4f0cf457f26ae436936048932ceb0db
ToppCellmyeloid-pro-pDC|myeloid / Lineage and Cell class

ILF2 CENPE DIAPH3 DCK TOP2A CEP55

2.88e-0719661670daf4fabb68aecc5cc9f03d6f6495dd29b74a16
ToppCell(10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition

SPAG1 SERBP1 AKAP9 RBBP6 ANKRD11 SPAG17

3.15e-0719961661b1ed2db71b96157b92b7535d1955a4033098da
ToppCell(5)_Dendritic_cell-(52)_cycling_DCs|(5)_Dendritic_cell / shred on Cell_type and subtype

DMXL2 CENPE DAB2 TOP2A MARCKS CEP55

3.15e-07199616d0ff446a197062b10f37b585f3f8716d6d89e5b7
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

AKAP9 PHF3 ANKRD11 SRSF11 SRRM2 UTRN

3.24e-0720061612f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellTransverse-Dendritic_cell-cycling_DCs|Transverse / Region, Cell class and subclass

DMXL2 CENPE DAB2 DIAPH3 TOP2A CEP55

3.24e-07200616f588d8889f351c797963616a3575fa43efd46b9a
ToppCellmoderate-Lymphoid-NKT-proliferating|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CENPE DIAPH3 TOP2A MARCKS CEP55 MSMB

3.24e-07200616693adc310953b669c9b93e2e7a3346606f75c810
ToppCellSepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class

CENPE TMEM237 DIAPH3 PSMA8 TOP2A CEP55

3.24e-07200616f277db6cc288a52a5426120c1067608700ee8ccc
ToppCellTransverse-(5)_Dendritic_cell-(52)_cycling_DCs|Transverse / shred on region, Cell_type, and subtype

DMXL2 CENPE DAB2 DIAPH3 TOP2A CEP55

3.24e-0720061651e643d48b5e97a0e117b578a6ea7d429c6cdd1e
ToppCell(52)_cycling_DCs|World / shred on Cell_type and subtype

DMXL2 CENPE DAB2 DIAPH3 TOP2A CEP55

3.34e-07201616ad2d25d84345fdd593065516a05c5c2b5429eac0
ToppCellEndothelial-H_(cycle)|World / shred on cell class and cell subclass (v4)

ILF2 CENPE DIAPH3 TOP2A CEP55

1.09e-061336158e3005114761feee028c496cc739e607b35d7831
ToppCellDividing_Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

CENPE RNF17 PSMA8 TOP2A CEP55

1.85e-0614861566b51aa6690bf8fbc90fa5a6f86191703e2d5046
ToppCell3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue

CENPE DIAPH3 SPAG17 TOP2A CEP55

2.96e-0616361547300dec94dc66e965bf71fafff0a9fd24fae968
ToppCellPND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CENPE DIAPH3 RNF17 TOP2A CEP55

3.05e-06164615ae09e5aabd1347b865474255e7411c04f63efb3b
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

ILF2 CENPE TOP2A MARCKS CEP55

3.85e-061726157f3d0ef18f5df1ed80498d435b0378ca398c0b88
ToppCellPND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DMXL2 CENPE DIAPH3 TOP2A CEP55

4.08e-0617461565147b0f8c2ccadd5685430d31081520c157536a
ToppCelldroplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CENPE DIAPH3 RNF17 TOP2A CEP55

4.19e-0617561573f25bd54309aed1480ddc44bdab518b17e71f92
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CENPE FAM186A DIAPH3 TOP2A CEP55

4.43e-061776153081ce5fc66a1bb833719d6c0e0a6fc7115eeb91
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ILF2 CENPE TOP2A MARCKS CEP55

4.68e-061796156718cadcc2d3b64717ed84244ef1242d392662dc
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CENPE TMEM237 DIAPH3 TOP2A CEP55

4.81e-0618061542f48e646fc6e72ad3cce72409ace3a0b64020a2
ToppCellcontrol-Lymphoid-NKT-proliferating|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

RPLP1 CENPE DIAPH3 TOP2A CEP55

4.81e-06180615535535a67b3f3320bad2f98b1bc98a7b0ee77840
ToppCelldroplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LMAN1 RPLP1 SEC62 DAB2 TOP1

4.81e-0618061554e3f289a37d4cfbfca4fb284c3b52e9c7d9da97
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

ILF2 CENPE TOP2A MARCKS CEP55

4.81e-06180615ed4966765a6b25456f68185cf0648c4a3a21d7fe
ToppCell10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue

DMXL2 CENPE DAB2 TOP2A CEP55

4.81e-061806154eea8366cdb82c356325ce88f09ad8b302c17a07
ToppCelldroplet-Marrow-BM_(NON-STC)-30m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LMAN1 RPLP1 SEC62 DAB2 TOP1

4.81e-06180615bfc8568d57034dd9c9e07edae94479a48ca0706d
ToppCellIIH-cycling-|IIH / Condition, Cell_class and T cell subcluster

SPAG1 CENPE DIAPH3 TOP2A CEP55

4.94e-061816157f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078
ToppCellIIH-cycling|IIH / Condition, Cell_class and T cell subcluster

SPAG1 CENPE DIAPH3 TOP2A CEP55

4.94e-06181615ec3e782ce93dcfe1a54fb7284e4e39063614b0e2
ToppCellPND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DMXL2 CENPE DIAPH3 DCK TOP2A

5.08e-0618261521dcab170ffeef89faa9fee5008568cb6e15c694
ToppCelldroplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHF3 ANKRD11 FCHO2 TAF7 UTRN

5.35e-061846151154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CENPE DIAPH3 PSMA8 TOP2A CEP55

5.35e-061846158260e688ec42a1374727bc85dceb7edd19a8b662
ToppCellURO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type

CENPE TMEM237 DIAPH3 TOP2A CEP55

5.50e-061856150ae9c646679c69a553eda670aef0e0495feb0286
ToppCell10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue

DST CENPE DIAPH3 TOP2A CEP55

5.50e-061856159d3168c7f0b1d739f78b368969cf5c77ce202b97
ToppCellDividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

CENPE DIAPH3 TOP2A MARCKS CEP55

5.64e-061866150067eb78d4c7e32b9563550d9fcaf13445ee6a48
ToppCelldroplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TAF3 AKAP9 ANKRD11 SRRM2 TOP1

5.79e-06187615663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCellILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

DST AKAP9 DAB2 FCHO2 UTRN

5.79e-061876150099def970fbc828756fbf853eca2ce77b8cd342
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TPM4 CENPE DIAPH3 TOP2A CEP55

5.94e-0618861515146fd2c5592ea84d20b1fdd172b39cd60b5bed
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SERBP1 DST AKAP9 ANKRD11 UTRN

6.26e-06190615d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCelldroplet-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CENPE DCK TOP1 TOP2A MARCKS

6.58e-06192615041124dd5c24c1eb188d2560ba606422c0b215c5
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

AKAP9 PHF3 SRRM2 UTRN MARCKS

6.58e-06192615916fbec1c7ab7969bda711886ac88e877e30c280
ToppCelldroplet-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CENPE DCK TOP1 TOP2A MARCKS

6.58e-06192615d9e61b2722aa81e4f6e11865a04f2f1e75b794ab
ToppCellSevere_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）

DST CENPE DIAPH3 TOP2A CEP55

6.75e-061936150d85025690c9cd545cba30abc38acbdd6a39b153
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

AKAP9 PHF3 SRRM2 UTRN MARCKS

6.75e-06193615e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

TPM4 CENPE DIAPH3 TOP2A CEP55

6.92e-0619461517af04acd54dd6a895a966cbb4422de25dc4f1e6
ToppCellP03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CENPE DIAPH3 DCK TOP2A CEP55

6.92e-0619461522bcfb0f3f73608feb22c0847ab4d34f87aeede0
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DST AKAP9 COX16 SEC62 TOP2A

6.92e-0619461540c6e17e9e48d4fa6da3a0a1066c4c6565a1e096
ToppCellBAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DST CENPE DIAPH3 TOP2A CEP55

6.92e-06194615cb39850e9577015b6b9834e98c36b412bae7d462
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CENPE DIAPH3 DCK TOP2A CEP55

6.92e-06194615e5b81a8e52259a54a911c1c2ac932c98c988318d
ToppCellBAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DST CENPE DIAPH3 TOP2A CEP55

6.92e-06194615408597c9aa302a44b112c1d612c21fbb0227a82a
ToppCellBAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DST CENPE DIAPH3 TOP2A CEP55

6.92e-06194615193cc20fefbd795a4ad59e401a95af47d30603e7
ToppCellP03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CENPE DIAPH3 DCK TOP2A CEP55

6.92e-061946155e56ce9b9fe0721be3a9e6efe1422599bb867721
ToppCellBAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DST CENPE DIAPH3 TOP2A CEP55

6.92e-061946152360b5f995b360419de41612368cab9fb61781a1
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

TPM4 CENPE DIAPH3 TOP2A CEP55

6.92e-061946153c385d93c5fe1a7817813c492f79fdb94d887357
ToppCellBAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

DST CENPE DIAPH3 TOP2A CEP55

6.92e-06194615903ae11708b0cb24538c6982abd57fe6fa95b8d3
ToppCelldroplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DMXL2 DAB2 DCK TOP2A CEP55

6.92e-06194615effd38e51062b225ecabc7e1c50154e65495d559
ToppCellBAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

DST CENPE DIAPH3 TOP2A CEP55

6.92e-0619461558406502a8cbcc3037f79a1b6a683df408297ae5
ToppCellBLOOD--(1)_T_cell-(1)_Activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

TPM4 CENPE DIAPH3 TOP2A CEP55

6.92e-061946156a0cbb9d5c5c4effb02dff654c6c3b184026875c
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

TPM4 CENPE DIAPH3 TOP2A CEP55

6.92e-06194615635d0e88f9c542a1d9363066c6cdbc6e44db76c1
ToppCell(7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

CENPE DIAPH3 DCK TOP2A CEP55

6.92e-061946154d6ae2b25db11a4ae6dadee83be5c8c05b1225c3
ToppCell10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue

LMAN1 CENPE DIAPH3 TOP2A CEP55

7.10e-061956151390728b9a514db534e8bc6dcf72cf51a1065780
ToppCellBLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

TPM4 CENPE DIAPH3 TOP2A CEP55

7.10e-0619561545515d5da8a8c8242eb70a1bea24fe44eca5407b
ToppCellE18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CENPE DIAPH3 TOP2A MARCKS CEP55

7.10e-06195615a838bddeed487154791b69d27a68673783ff63c0
ToppCellSepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class

CENPE RASA4B PSMA8 TOP2A CEP55

7.28e-06196615e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.

CENPE DIAPH3 UTRN TOP2A CEP55

7.28e-061966155905f0e3061a6b98b7a33d64c782c3dda2cd51ef
ToppCellsevere_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2)

CENPE TMEM237 DIAPH3 TOP2A CEP55

7.46e-06197615189d97a6c2ff8803db8cc05e205c9d88dac3911f
ToppCellproximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CENPE DIAPH3 PSMA8 TOP2A CEP55

7.46e-061976150b1fa881abbfcc54b322fc27124db3f8947af016
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CENPE DIAPH3 DCK TOP2A CEP55

7.46e-061976157eb4c1cffd0366204af7e63adc8f751685601a94
ToppCellproximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CENPE DIAPH3 PSMA8 TOP2A CEP55

7.46e-061976150dd9058aa19d1268ebba9a65555870224b5a5978
ToppCell10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ILF2 SRSF11 TAF7 DCK TOP2A

7.46e-06197615106b0f9a0425facc634feb7498c9ba2c55edfbf8
ToppCellLPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type

CENPE EVC DIAPH3 TOP2A CEP55

7.46e-06197615038fd92750257d43d5e980fd06d77742b543f11a
ToppCellproximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CENPE DIAPH3 PSMA8 TOP2A CEP55

7.46e-061976159243617b307acf3df40d93c41cd8d4788699a7ea
ToppCellsevere_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2)

CENPE TMEM237 DIAPH3 TOP2A CEP55

7.64e-06198615ed86b0247006befe55400c287d334d2202b470bd
ToppCell5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ILF2 CENPE TOP2A MARCKS CEP55

7.64e-06198615c3dd887c95587f930b7afd32385627a9fa029ca4
ToppCellnormal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass

TPM4 CENPE DIAPH3 TOP2A CEP55

7.64e-0619861547d572b9db2843aeb2079f33a852babf67270be4
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

TAF3 AKAP9 RBBP6 ANKRD11 UTRN

7.64e-0619861576d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

LMAN1 CENPE DIAPH3 TOP2A CEP55

7.64e-061986152d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24
ToppCellSigmoid-Dendritic_cell-cycling_DCs|Sigmoid / Region, Cell class and subclass

CENPE DAB2 DIAPH3 TOP2A CEP55

7.83e-06199615bd6f8c0f79e9a94cc0f8c6105d38851463de821c
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CENPE DIAPH3 DCK TOP2A CEP55

7.83e-0619961513ff6c26ebcc663ef8e5559ab9be99dab848abe7
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

AKAP9 PHF3 ANKRD11 SRSF11 UTRN

7.83e-06199615f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellLeuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type

CENPE TMEM237 DIAPH3 TOP2A CEP55

7.83e-0619961587113d398585076ece86b9098781e817f8ca241b
ToppCellSigmoid-(5)_Dendritic_cell-(52)_cycling_DCs|Sigmoid / shred on region, Cell_type, and subtype

CENPE DAB2 DIAPH3 TOP2A CEP55

7.83e-061996158ee78a39729633bcbb3ab17e1dfaca33f38db569
ToppCellMild/Remission-Developping_Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

LMAN1 CENPE DIAPH3 TOP2A CEP55

7.83e-0619961558c772ec763109a4009f52424fbb214fc23d0c09
ToppCell3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SERBP1 RPLP1 CENPE MRPL1 TOP2A

7.83e-061996150649a2c5b8b1f01bb4c4d1eb114cf78a32f8ccd8
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

DST AKAP9 PHF3 ANKRD11 UTRN

7.83e-06199615c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SERBP1 RPLP1 CENPE MRPL1 TOP2A

7.83e-06199615e3e28981783b922027cee7fe8863386b02c7c758
ToppCellcritical-Lymphoid-NKT-proliferating|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CENPE DIAPH3 TOP2A CEP55 MSMB

7.83e-061996159284956d852e434a91be892e88e06a7c71f8c583
ToppCellILEUM-non-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

TPM4 CENPE DIAPH3 TOP2A CEP55

7.83e-06199615f9bf94ab6b5b134f5b98a65340843b147941ab58
ToppCellSepsis-URO-Lymphocyte-B-Plasmablast|URO / Disease, condition lineage and cell class

LMAN1 CENPE PSMA8 TOP2A CEP55

7.83e-061996150df6cafb7f3b607cbe80b6f25b4fd62d421d01ee
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

AKAP9 PHF3 ANKRD11 UTRN

4.52e-0549444GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
DrugVitamin K 3

SERBP1 ILF2 AKAP9 TMEM237 RBBP6 IARS1 ANKRD11 AUTS2 SRSF11 KAT2A SRRM2 TOP1 TOP2A MSMB

3.35e-0612496014ctd:D024483
Drugbatracylin

TOP1 TOP2A

6.83e-062602ctd:C057924
Drugboswellic acid

TOP1 TOP2A

6.83e-062602ctd:C054625
Drug4,4'-dipyridylamine

DST SPAG17

2.05e-053602CID000225529
DrugLucanthone

TOP1 TOP2A

2.05e-053602DB04967
DiseaseBlood Platelet Disorders

TPM4 FERMT3

4.79e-0416602C0005818

Protein segments in the cluster

PeptideGeneStartEntry
VDVKFKEEFKPLSKE

AKAP9

1506

Q99996
DKERKEKTKPERYKE

ANKRD11

1016

Q6UB99
KLEGKELEEYLEKEK

CPSF2

386

Q9P2I0
DSEDEEPKKYRIEIK

FCHO2

346

Q0JRZ9
KKPESEGYLQEEKQK

CEP55

221

Q53EZ4
YKPHKEDMEKKETEI

DMXL2

861

Q8TDJ6
YDAVKSKMDPELEKK

COX16

41

Q9P0S2
KLEEFEEKASELYKK

DIAPH3

501

Q9NSV4
PDNKEEAEKKFKLVS

DNAJB8

36

Q8NHS0
DKETPEEVIAKLYKL

AP4E1

526

Q9UPM8
FEEKKYVELDPSKVE

RASA4

376

O43374
KKKKEVKEEGSPDSY

RARG

166

P13631
FEEKKYVELDPSKVE

RASA4B

376

C9J798
KEKGKELKDPDQLYT

KAT2A

721

Q92830
DPFEVLKAAENKKKE

SERBP1

26

Q8NC51
KEKKKGPEKTDEYLL

DAB2

26

P98082
KDAYKPITDADKIED

DST

7266

Q03001
DDEEKEKKYMLPLDN

DNM3

561

Q9UQ16
EESLYKPGAKKKIDE

CYLC1

546

P35663
YENPKKSSEVKVKEE

AUTS2

971

Q8WXX7
IKPEEAKVYEDEKRI

NOD1

936

Q9Y239
TPDKEISEKEKEKYQ

LMAN1

276

P49257
EDCKYIVVEKKDPKK

MSMB

91

P08118
AAPAEEKKVEAKKEE

RPLP1

86

P05386
ETKPVKEEKVKKDYS

RBBP6

1101

Q7Z6E9
KYPEKESEPSEKIQK

RBBP6

1361

Q7Z6E9
EGKDYSKEPSKEDRK

CHD1L

576

Q86WJ1
KAYEKPPEKKEGEEE

ILF2

356

Q12905
KVEKYEEKEKTGPVL

BIN3

141

Q9NQY0
KAAEEPSKVEEKKAE

MARCKS

256

P29966
LYEKADIKGPEDKKK

ATP5F1C

76

P36542
DFKDKYESLVEKVKE

DCK

241

P27707
DLLPKKKSDDELYQK

EVC

246

P57679
YKDTKKEEQVGEKPI

FAM186A

736

A6NE01
KPYKEEIEDLKMKLV

CENPE

2451

Q02224
PKKIIKKPEYDLEED

ORC2

46

Q13416
EKEKDKETGRETKYP

TAF3

561

Q5VWG9
KEEEADPYKFKIKEF

TAF3

581

Q5VWG9
TAKKKYIESPDVEKE

TAF7

151

Q15545
VETLPRKYKKECEEE

UTRN

266

P46939
FYEDIKKDPKREIEK

SULT1C3

201

Q6IMI6
PSSPYEDKDKDKKEK

SRRM2

331

Q9UQ35
IIEMYEPDEDLKKKG

PLCB4

271

Q15147
KEDEEYKRVDFSKVP

ACAT1

251

P24752
DPEALKDIKSLEKYI

IARS1

856

P41252
NDPKEIVKKEEKGDY

SPAG17

1076

Q6Q759
KKTVDEKEVLKYLPD

CNGA1

441

P29973
KEKPRSDHDKKYEEE

RNF17

1366

Q9BXT8
SSEVEEYPDKEKEIK

TMEM237

391

Q96Q45
TPDEKKDEIEKIKAY

MRPL1

61

Q9BYD6
VKVEEKEEKGKYLPS

ZSCAN21

26

Q9Y5A6
KEDKYEEEIKLLSDK

TPM4

181

P67936
YKGPKADLKKDEKSE

SEC62

286

Q99442
GYDSEKEKKEEKKPI

SRSF11

431

Q05519
VEKECLKIDEDYKEK

SPAG1

166

Q07617
NVDKKPDKPKSEDYE

PHF3

1991

Q92576
PDKPKSEDYEKDKER

PHF3

1996

Q92576
KKKEKEPEEELYDLS

FERMT3

151

Q86UX7
TKKDEDPENKIEFKT

IK

196

Q13123
CKYKIEKIETIKPEE

SUCO

1111

Q9UBS9
KKPIKYLEESDEDDL

TOP2A

1516

P11388
YVTEIEKEKEEAEKK

PSMA8

236

Q8TAA3
KSIEPYLKKKDESQE

SDHB

151

P21912
DEDDADYKPKKIKTE

TOP1

141

P11387